BAT subsidiary deepens its strategic partnership with Organigram by investing approximately £74 million to increase its equity stake from 19% to 45% and support product development in the cannabis industry.

Information on the Target

Organigram Holdings Inc. (Organigram) is a prominent licensed producer of cannabis based in Canada. The company stands out for its commitment to innovation, producing high-quality products for both adult-use and medical markets. As a publicly traded entity on NASDAQ and TSX, Organigram has developed a strong reputation for consumer-led product development and maintaining robust compliance with regulatory standards.

What sets Organigram apart is its strategic focus on research and development, allowing for the continuous introduction of new products in the evolving cannabis market. This approach positions the company well to meet the diverse needs of consumers as cannabis utilization expands both recreationally and medicinally in Canada.

Industry Overview in Canada

The cannabis industry in Canada has witnessed significant evolution since legalization in 2018. The market has seen a surge in consumer interest, driven by an increasing acceptance of cann